199 Takotsubo syndrome associated mir-16 and mir-26a reduce contractility of cardiomyocytes in vitro by an inhibitory g-?protein dependent mechanism
199 Takotsubo syndrome associated mir-16 and mir-26a reduce contractility of cardiomyocytes in vitro by an inhibitory g-?protein dependent mechanism
复制标题
199 Takotsubo 综合征相关的 mir-16 和 mir-26a 通过抑制性 g-β 蛋白依赖性机制降低体外心肌细胞的收缩力
DOI:
10.1136/heartjnl-2017-311726.197
复制
发表时间:
2017
期刊:
影响因子:
5.7
通讯作者:
Couch L
中科院分区:
文献类型:
--
作者:
Couch L
IntroductionTakotsubo syndrome (TTS) is a severe but reversible acute heart failure affecting predominantly post-menopausal women, where ventricular apical akinesis results from extreme adrenaline levels arising with stress. The pleiotropic β²AR signals via stimulatory (Gs) and inhibitory (Gi) G-proteins, and whilst Gsincreases cardiac output, it concomitantly decreases survival. The duality of β²AR is a homeostatic mechanism to limit cardiotoxicity by facilitating a switch to Gi, serving as cardioprotective despite being cardiodepressive. This is dysregulated in TTS where excess stimulus trafficking to Giresults in profound negative inotropy. It is not understood what predisposes patients to TTS, but a microRNA (miR) profile of increased miR-16 and miR-26a has been identified. Given the importance of miRs in other cardiac diseases and that TTS is thought to be causally related to β2AR-Gi, we hypothesise that these miRs could predispose to the cardiodepression in TTS.MethodmiRs were manipulated in adult rat apical cardiomyocytes with blinded transfection using Lipofectamine 3000. Percentage shortening was measured using an Ionoptix system, and pharmacological protocols applied. Calcium transients were obtained using Fluo-4-AM and sarcoplasmic reticulum (SR) calcium content measured with caffeine micro-application. N numbers displayed as n/N, where n/N=cells/rats.ResultsUp-regulation of miR-16 and miR-26a significantly reduced basal contractility (miR-16=3.520.34% versus control=4.910.46%; n/N=30/6; p<0.05 and miR-26a=2.770.21% versus control=4.300.43%; n/N=50/10; p<0.01), whereas down-regulation had no effect. miR-16/-26a manipulation did not alter β2AR response. Inhibiting Gi with pertussis toxin (PTX) prevented this (miR-16 untreated=5.080.49%, n=22; versus miR-16 PTX-treated=8.820.63%, n=20; p<0.001; and miR-26a untreated=3.200.29% versus miR-26a PTX-treated=5.050.48%; n/N=30/6; p<0.05 respectively). PTX-treatment did not change contractility of control transfected cells. No synergism was observed with dual miR-16/-26a transfection possibly suggesting a unified mechanism. Calcium transient amplitude was decreased with miR-16/-26a up-regulation (F/F0 for control=1.850.04, n/N=66/4 versus miR-16=1.510.04, n/N=37/4 and miR-26a=1.570.04, n/N=26/4; p<0.001), along with a concomitant decrease in SR calcium content (caffeine-induced F/F0 for control=3.130.14, n/N=32/4 versus miR-16=2.130.13, n/N=22/4 and miR-26a=2.570.19, n/N=17/4; p<0.001 and p<0.05 respectively).Conclusion/implicationIncreased miR-16/−26a reduce basal contractility of cardiomyocytesin vitro, possibly through a shared Gi-dependent mechanism. Decreased calcium transient amplitude is also likely to contribute. This suggests these miRs may be mechanistically involved in TTS, but further work is needed to investigate their specific mechanistic and spatiotemporal involvement.